Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 20.18
-0.93 (-4.41%)
Jun 2, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 3.99 billion as of June 2, 2026. Its market cap has decreased by -45.40% in one year.
Market Cap
3.99B
Enterprise Value
4.78B
Revenue
1.46B
Ranking
n/a
PE Ratio
35.58
Stock Price
20.18
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 3.99B, a decrease of -51.00%. That is a compound annual growth rate of -12.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 3.99B | -36.36% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Wecome Pharmaceutical Company | 4.53B |
| Jiangsu Bioperfectus Technologies | 4.47B |
| Lifecome Biochemistry | 4.42B |
| Assure Tech (Hangzhou) | 4.35B |
| ChemPartner PharmaTech | 4.30B |
| Beijing Scitop Bio-tech | 4.27B |
| Wuhan Hvsen Biotechnology | 4.24B |
| Beijing Bohui Innovation Biotechnology Group | 4.16B |